139 related articles for article (PubMed ID: 28843268)
1. Effects of a Phosphoinositide-3-Kinase Inhibitor on Anaplastic Thyroid Cancer Stem Cells.
Bozorg-Ghalati F; Hedayati M; Dianatpour M; Azizi F; Mosaffa N; Mehrabani D
Asian Pac J Cancer Prev; 2017 Aug; 18(8):2287-2291. PubMed ID: 28843268
[TBL] [Abstract][Full Text] [Related]
2. Inverse Agonist of Estrogen-Related Receptor γ Enhances Sodium Iodide Symporter Function Through Mitogen-Activated Protein Kinase Signaling in Anaplastic Thyroid Cancer Cells.
Singh TD; Jeong SY; Lee SW; Ha JH; Lee IK; Kim SH; Kim J; Cho SJ; Ahn BC; Lee J; Jeon YH
J Nucl Med; 2015 Nov; 56(11):1690-6. PubMed ID: 26338896
[TBL] [Abstract][Full Text] [Related]
3. Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells.
Kogai T; Sajid-Crockett S; Newmarch LS; Liu YY; Brent GA
J Endocrinol; 2008 Nov; 199(2):243-52. PubMed ID: 18762555
[TBL] [Abstract][Full Text] [Related]
4. Targeting the BRAF Signaling Pathway in CD133pos Cancer Stem Cells of Anaplastic Thyroid Carcinoma.
Bozorg-Ghalati F; Hedayati M; Dianatpour M; Mosaffa N; Azizi F
Asian Pac J Cancer Prev; 2019 May; 20(5):1353-1360. PubMed ID: 31127889
[TBL] [Abstract][Full Text] [Related]
5. A Novel Tyrosine Kinase Inhibitor Can Augment Radioactive Iodine Uptake Through Endogenous Sodium/Iodide Symporter Expression in Anaplastic Thyroid Cancer.
Oh JM; Baek SH; Gangadaran P; Hong CM; Rajendran RL; Lee HW; Zhu L; Gopal A; Kalimuthu S; Jeong SY; Lee SW; Lee J; Ahn BC
Thyroid; 2020 Apr; 30(4):501-518. PubMed ID: 31928162
[No Abstract] [Full Text] [Related]
6. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.
Reddi HV; Madde P; McDonough SJ; Trujillo MA; Morris JC; Myers RM; Peng KW; Russell SJ; McIver B; Eberhardt NL
Cancer Gene Ther; 2012 Sep; 19(9):659-65. PubMed ID: 22790962
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells.
Pugliese M; Fortunati N; Germano A; Asioli S; Marano F; Palestini N; Frairia R; Boccuzzi G; Catalano MG
Thyroid; 2013 Jul; 23(7):838-46. PubMed ID: 23531031
[TBL] [Abstract][Full Text] [Related]
8. Regulation of iodine-glucose flip-flop in SW1736 anaplastic thyroid cancer cell line.
Heydarzadeh S; Moshtaghie AA; Daneshpour M; Hedayati M
J Endocrinol Invest; 2024 May; ():. PubMed ID: 38698299
[TBL] [Abstract][Full Text] [Related]
9. Reverting iodine avidity of radioactive-iodine refractory thyroid cancer with a new tyrosine kinase inhibitor (K905-0266) excavated by high-throughput NIS (sodium iodide symporter) enhancer screening platform using dual reporter gene system.
Oh JM; Kalimuthu S; Gangadaran P; Baek SH; Zhu L; Lee HW; Rajendran RL; Hong CM; Jeong SY; Lee SW; Lee J; Ahn BC
Oncotarget; 2018 Jan; 9(6):7075-7087. PubMed ID: 29467951
[TBL] [Abstract][Full Text] [Related]
10. Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer.
Haghpanah V; Fallah P; Tavakoli R; Naderi M; Samimi H; Soleimani M; Larijani B
Tumour Biol; 2016 Jan; 37(1):1299-308. PubMed ID: 26289851
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.
Altmann A; Markert A; Askoxylakis V; Schöning T; Jesenofsky R; Eisenhut M; Haberkorn U
J Nucl Med; 2012 Nov; 53(11):1764-71. PubMed ID: 23055533
[TBL] [Abstract][Full Text] [Related]
12. Illuminating the role of lncRNAs ROR and MALAT1 in cancer stemness state of anaplastic thyroid cancer: An exploratory study.
Mahdiannasser M; Khazaei S; Akhavan Rahnama M; Soufi-Zomorrod M; Soutodeh F; Parichehreh-Dizaji S; Rakhsh-Khorshid H; Samimi H; Haghpanah V
Noncoding RNA Res; 2023 Sep; 8(3):451-458. PubMed ID: 37455764
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
[TBL] [Abstract][Full Text] [Related]
14. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
[TBL] [Abstract][Full Text] [Related]
15. Increasing the effectiveness of radioactive iodine therapy in the treatment of thyroid cancer using Trichostatin A, a histone deacetylase inhibitor.
Zarnegar R; Brunaud L; Kanauchi H; Wong M; Fung M; Ginzinger D; Duh QY; Clark OH
Surgery; 2002 Dec; 132(6):984-90; discussion 990. PubMed ID: 12490845
[TBL] [Abstract][Full Text] [Related]
16. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
Jeong H; Kim YR; Kim KN; Choe JG; Chung JK; Kim MK
Nucl Med Biol; 2006 Oct; 33(7):875-82. PubMed ID: 17045167
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of ¹³¹I by carbamazepine in breast cancer cells.
Willhauck MJ; O Kane DJ; Wunderlich N; Göke B; Spitzweg C
Breast Cancer Res Treat; 2011 Jan; 125(2):377-86. PubMed ID: 20300827
[TBL] [Abstract][Full Text] [Related]
18. Switching from MAPK-dependent to MAPK-independent repression of the sodium-iodide symporter in 2D and 3D cultured normal thyroid cells.
Ingeson-Carlsson C; Nilsson M
Mol Cell Endocrinol; 2013 Dec; 381(1-2):241-54. PubMed ID: 23969277
[TBL] [Abstract][Full Text] [Related]
19. Lipid-Peptide-mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer.
Li Q; Zhang L; Lang J; Tan Z; Feng Q; Zhu F; Liu G; Ying Z; Yu X; Feng H; Yi H; Wen Q; Jin T; Cheng K; Zhao X; Ge M
Adv Sci (Weinh); 2023 Jan; 10(3):e2204334. PubMed ID: 36453580
[TBL] [Abstract][Full Text] [Related]
20. All-trans retinoic acid suppresses malignant characteristics of CD133-positive thyroid cancer stem cells and induces apoptosis.
Mei D; Lv B; Chen B; Xiao S; Jiang J; Xie Y; Jiang L
PLoS One; 2017; 12(8):e0182835. PubMed ID: 28817605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
